9-111530950-A-G
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_133464.5(ZNF483):c.488A>G(p.Asn163Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000203 in 1,527,164 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_133464.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF483 | ENST00000309235.6 | c.488A>G | p.Asn163Ser | missense_variant | Exon 3 of 6 | 1 | NM_133464.5 | ENSP00000311679.5 | ||
ZNF483 | ENST00000355824.7 | c.488A>G | p.Asn163Ser | missense_variant | Exon 3 of 6 | 1 | ENSP00000438048.1 | |||
ZNF483 | ENST00000358151.8 | c.488A>G | p.Asn163Ser | missense_variant | Exon 3 of 6 | 2 | ENSP00000350871.4 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151438Hom.: 0 Cov.: 26 show subpopulations
GnomAD2 exomes AF: 0.0000501 AC: 12AN: 239498 AF XY: 0.0000617 show subpopulations
GnomAD4 exome AF: 0.0000211 AC: 29AN: 1375726Hom.: 3 Cov.: 23 AF XY: 0.0000263 AC XY: 18AN XY: 685272 show subpopulations
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151438Hom.: 0 Cov.: 26 AF XY: 0.0000271 AC XY: 2AN XY: 73900 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.488A>G (p.N163S) alteration is located in exon 3 (coding exon 2) of the ZNF483 gene. This alteration results from a A to G substitution at nucleotide position 488, causing the asparagine (N) at amino acid position 163 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at